Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.
Status:
Completed
Trial end date:
2012-06-17
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to see how safe GSK1995057 is and how well it is tolerated
after dosing. The study will also investigate how GSK1995057 is taken up, metabolised
(chemically broken down), distributed through the body and excreted, and what some of the
effects of the study drug are.